Cell-based antiviral screening against coronaviruses: Developing virus-specific and broad-spectrum inhibitors

Antiviral Research

Volumn 101, Issue 1, 2014, Pages 105-112

  Kilianski, Andy ^a   Baker, Susan C ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Antivirals; Entry inhibitors; MERS CoV; pGlo; Replicase inhibitors; SARS CoV

Indexed keywords

ANTIVIRUS AGENT; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOPHILIN; CYCLOSPORIN A; CYSTEINE PROTEINASE INHIBITOR; ENFUVIRTIDE; MARAVIROC; PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR;

ANTIVIRAL THERAPY; CORONAVIRUS; DRUG TARGETING; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RNA REPLICATION; SCREENING; SEVERE ACUTE RESPIRATORY SYNDROME; CORONAVIRUS INFECTION; DRUG SCREENING; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; CELL LINE; CORONAVIRINAE; DRUG EFFECT; ISOLATION AND PURIFICATION; PRECLINICAL STUDY; PROCEDURES;

CORONAVIRUS; SARS CORONAVIRUS;

ANTIVIRALS; ENTRY INHIBITORS; MERS-COV; PGLO; REPLICASE INHIBITORS; SARS-COV;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CORONAVIRUS; DRUG EVALUATION, PRECLINICAL; HUMANS;

EID: 84889057464     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.11.004     Document Type: Review

References (77)

1. A.O. Adedeji, K. Singh, N.E. Calcaterra, M.L. DeDiego, L. Enjuanes, S. Weiss, and S.G. Sarafianos Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase Antimicrobial Agents and Chemotherapy 56 9 2012 4718 4728 10.1128/AAC.00957-12
2. A.O. Adedeji, W. Severson, C. Jonsson, K. Singh, S.R. Weiss, and S.G. Sarafianos Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms Journal of Virology 87 14 2013 8017 8028 10.1128/JVI.00998-13
3. D.G. Ahn, W. Lee, J.K. Choi, S.J. Kim, E.P. Plant, F. Almazan, and J.W. Oh Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication Antiviral Research 91 1 2011 1 10 10.1016/j.antiviral.2011.04.009
4. F. Almazan, M.L. Dediego, C. Galan, D. Escors, E. Alvarez, J. Ortego, and L. Enjuanes Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis Journal of Virology 80 21 2006 10900 10906 10.1128/JVI.00385-06 (Pubitemid 44628940)
5. F. Almazan, M.L. DeDiego, I. Sola, S. Zuniga, J.L. Nieto-Torres, S. Marquez-Jurado, and L. Enjuanes Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate mBio 4 5 2013 e00650 13 10.1128/mBio.00650-13
6. K. Anand, J. Ziebuhr, P. Wadhwani, J.R. Mesters, and R. Hilgenfeld Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs Science (New York, N.Y.) 300 5626 2003 1763 1767 10.1126/science.1085658 (Pubitemid 36712575)
7. D.L. Barnard, and Y. Kumaki Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy Future Virology 6 5 2011 615 631 10.2217/fvl.11.33
8. N. Barretto, D. Jukneliene, K. Ratia, Z. Chen, A.D. Mesecar, and S.C. Baker The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity Journal of Virology 79 24 2005 15189 15198 10.1128/JVI.79.24.15189-1.5198.2005 (Pubitemid 43032301)
9. J.E. Blanchard, N.H. Elowe, C. Huitema, P.D. Fortin, J.D. Cechetto, L.D. Eltis, and E.D. Brown High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase Chemistry & Biology 11 10 2004 1445 1453 10.1016/j.chembiol.2004.08.011 (Pubitemid 39365165)
10. Z. Chen, Y. Wang, K. Ratia, A.D. Mesecar, K.D. Wilkinson, and S.C. Baker Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63 Journal of Virology 81 11 2007 6007 6018 10.1128/JVI.02747-06 (Pubitemid 46847037)
11. Y. Chen, K.R. Rajashankar, Y. Yang, S.S. Agnihothram, C. Liu, Y.L. Lin, and F. Li Crystal structure of the receptor-binding domain from newly emerged middle east respiratory syndrome coronavirus Journal of Virology 87 19 2013 10777 10783 10.1128/JVI.01756-13
12. V.C. Cheng, J.F. Chan, K.K. To, and K.Y. Yuen Clinical management and infection control of SARS: lessons learned Antiviral Research 100 2 2013 407 419 10.1016/j.antiviral.2013.08.016
13. C.Y. Chou, C.H. Chien, Y.S. Han, M.T. Prebanda, H.P. Hsieh, B. Turk, and X. Chen Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus Biochemical Pharmacology 75 8 2008 1601 1609 10.1016/j.bcp.2008.01.005
14. A.H. de Wilde, V.S. Ray, D. Oudshoorn, T.M. Bestebroer, S. van Nieuwkoop, R.W. Limpens, and B.G. van den Hoogen Human coronavirus-EMC replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment The Journal of General Virology 2013 10.1099/vir.0.052910-0
15. E. de Wit, J. Prescott, L. Baseler, T. Bushmaker, T. Thomas, M.G. Lackemeyer, and V.J. Munster The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in syrian hamsters PloS One 8 7 2013 e69127 10.1371/journal.pone.0069127
16. E. de Wit, A.L. Rasmussen, D. Falzarano, T. Bushmaker, F. Feldmann, D.L. Brining, and V.J. Munster Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques Proceedings of the National Academy of Sciences of the United States of America 2013 10.1073/pnas.1310744110
17. S.G. Devaraj, N. Wang, Z. Chen, Z. Chen, M. Tseng, N. Barretto, and K. Li Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus The Journal of Biological Chemistry 282 44 2007 32208 32221 10.1074/jbc.M704870200 (Pubitemid 350106468)
18. L. Du, G. Zhao, Z. Kou, C. Ma, S. Sun, V.K. Poon, and S. Jiang Identification of receptor-binding domain in S protein of the novel human coronavirus MERS-CoV as an essential target for vaccine development Journal of Virology 2013 10.1128/JVI.01048-13
19. D. Falzarano, E. de Wit, A.L. Rasmussen, F. Feldmann, A. Okumura, D.P. Scott, and H. Feldmann Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nature Medicine 2013 10.1038/nm.3362
20. M. Frieman, K. Ratia, R.E. Johnston, A.D. Mesecar, and R.S. Baric Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling Journal of Virology 83 13 2009 6689 6705 10.1128/JVI.02220-08
21. M. Frieman, D. Basu, K. Matthews, J. Taylor, G. Jones, R. Pickles, and D.A. Engel Yeast based small molecule screen for inhibitors of SARS-CoV PloS One 6 12 2011 e28479 10.1371/journal.pone.0028479
22. S. Fukushi, T. Mizutani, M. Saijo, S. Matsuyama, N. Miyajima, F. Taguchi, and S. Morikawa Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein The Journal of General Virology 86 Pt 8 2005 2269 2274 10.1099/vir.0.80955-0 (Pubitemid 41057531)
23. J. Gao, G. Lu, J. Qi, Y. Li, Y. Wu, Y. Deng, and G.F. Gao Structure of the fusion core and inhibition of fusion by a heptad-repeat peptide derived from the S protein of MERS-CoV Journal of Virology 2013 10.1128/JVI.02433-13
24. F. Ge, Y. Luo, P.X. Liew, and E. Hung Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening Virology 360 1 2007 150 158 10.1016/j.virol.2006.10.016 (Pubitemid 46335714)
25. F. Ge, S. Xiong, F.S. Lin, Z.P. Zhang, and X.E. Zhang High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery Antiviral Research 80 2 2008 107 113 10.1016/j.antiviral.2008.05.005
26. X.Y. Ge, J.L. Li, X.L. Yang, A.A. Chmura, G. Zhu, J.H. Epstein, and Z.L. Shi Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor Nature 2013 10.1038/nature12711
27. S. Gierer, S. Bertram, F. Kaup, F. Wrensch, A. Heurich, A. Kramer-Kuhl, and S. Pohlmann The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies Journal of Virology 87 10 2013 5502 5511 10.1128/JVI.00128-13
28. T. Giroglou, J. Cinatl Jr.; H. Rabenau, C. Drosten, H. Schwalbe, H.W. Doerr, and D. von Laer Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein Journal of Virology 78 17 2004 9007 9015 10.1128/JVI.78.17.9007-9015.2004 (Pubitemid 39096512)
29. I. Glowacka, S. Bertram, M.A. Muller, P. Allen, E. Soilleux, S. Pfefferle, and S. Pohlmann Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response Journal of Virology 85 9 2011 4122 4134 10.1128/JVI.02232-10
30. D.P. Han, A. Penn-Nicholson, and M.W. Cho Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor Virology 350 1 2006 15 25 10.1016/j.virol.2006.01.029 (Pubitemid 43850586)
31. T.J. Henrich, and D.R. Kuritzkes HIV-1 entry inhibitors: recent development and clinical use Current Opinion in Virology 3 1 2013 51 57 10.1016/j.coviro.2012.12.002
32. R. Hilgenfeld, and M. Peiris From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses Antiviral Research 100 1 2013 286 295 10.1016/j.antiviral.2013.08.015
33. H. Hofmann, K. Hattermann, A. Marzi, T. Gramberg, M. Geier, M. Krumbiegel, and S. Pohlmann S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients Journal of Virology 78 12 2004 6134 6142 10.1128/JVI.78.12.6134-6142.2004 (Pubitemid 38715911)
34. L. Josset, V.D. Menachery, L.E. Gralinski, S. Agnihothram, P. Sova, V.S. Carter, and M.G. Katze Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus mBio 4 3 2013 10.1128/mBio. 00165-13
35. R.Y. Kao, W.H. Tsui, T.S. Lee, J.A. Tanner, R.M. Watt, J.D. Huang, and K.Y. Yuen Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics Chemistry & Biology 11 9 2004 1293 1299 10.1016/j.chembiol.2004.07.013 (Pubitemid 39282803)
36. M. Kawase, K. Shirato, L. van der Hoek, F. Taguchi, and S. Matsuyama Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry Journal of Virology 86 12 2012 6537 6545 10.1128/JVI.00094-12
37. M. Ke, Y. Chen, A. Wu, Y. Sun, C. Su, H. Wu, and D. Guo Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2′-O-methyltransferase activity of nsp10/nsp16 complex Virus Research 167 2 2012 322 328 10.1016/j.virusres.2012.05.017
38. A. Kilianski, A. Mielech, X. Deng, and S.C. Baker Assessing activity and inhibition of MERS-CoV papain-like and 3C-like proteases using luciferase-based biosensors Journal of Virology 2013 10.1128/JVI.02105-13
39. F. Li Receptor recognition and cross-species infections of SARS coronavirus Antiviral Research 100 1 2013 246 254 10.1016/j.antiviral.2013.08. 014
40. C.W. Lin, C.H. Tsai, F.J. Tsai, P.J. Chen, C.C. Lai, L. Wan, and K.H. Lin Characterization of trans- and cis-cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti-SARS drugs FEBS Letters 574 1-3 2004 131 137 10.1016/j.febslet.2004.08.017 (Pubitemid 39200908)
41. I.J. Liu, C.L. Kao, S.C. Hsieh, M.T. Wey, L.S. Kan, and W.K. Wang Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors Antiviral Research 81 1 2009 82 87 10.1016/j.antiviral.2008.10.001
42. G. Lu, Y. Hu, Q. Wang, J. Qi, F. Gao, Y. Li, and G.F. Gao Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Nature 2013 10.1038/nature12328
43. S. Matsuyama, N. Nagata, K. Shirato, M. Kawase, M. Takeda, and F. Taguchi Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2 Journal of Virology 84 24 2010 12658 12664 10.1128/JVI.01542-10
44. Z.A. Memish, N. Mishra, K.J. Olival, S.F. Fagbo, V. Kapoor, and J.H. Epstein Middle East respiratory syndrome coronavirus in bats, Saudi Arabia Emerging Infectious Diseases 2013 0.3201/eid1911.131172 [Internet]
45. M.J. Moore, T. Dorfman, W. Li, S.K. Wong, Y. Li, J.H. Kuhn, and H. Choe Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2 Journal of Virology 78 19 2004 10628 10635 10.1128/JVI.78.19.10628-10635.2004 (Pubitemid 39258389)
46. H. Mou, V.S. Raj, F.J. van Kuppeveld, P.J. Rottier, B.L. Haagmans, and B.J. Bosch The receptor binding domain of the new MERS coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies Journal of Virology 2013 10.1128/JVI.01277-13
47. M.A. Muller, V.S. Raj, D. Muth, B. Meyer, S. Kallies, S.L. Smits, and C. Drosten Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines mBio 3 6 2012 10.1128/mBio. 00515-12
48. V.J. Munster, E. de Wit, and H. Feldmann Pneumonia from human coronavirus in a macaque model The New England Journal of Medicine 368 16 2013 1560 1562 10.1056/NEJMc1215691
49. L. Ni, J. Zhu, J. Zhang, M. Yan, G.F. Gao, and P. Tien Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain Biochemical and Biophysical Research Communications 330 1 2005 39 45 10.1016/j.bbrc.2005.02.117 (Pubitemid 40394933)
50. K. Ohnuma, B.L. Haagmans, R. Hatano, V.S. Raj, H. Mou, S. Iwata, and C. Morimoto Inhibition of middle east respiratory syndrome coronavirus (MERS-CoV) infection by anti-CD26 monoclonal antibody Journal of Virology 2013 10.1128/JVI.02448-13
51. R. Perera, P. Wang, M. Gomaa, R. El-Shesheny, A. Kandeil, O. Bagato, and G. Kayali Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013 Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 18 36 2013 20574
52. S. Pfefferle, J. Schopf, M. Kogl, C.C. Friedel, M.A. Muller, J. Carbajo-Lozoya, and A. von Brunn The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors PLoS Pathogens 7 10 2011 e1002331 10.1371/journal.ppat.1002331
53. V.S. Raj, H. Mou, S.L. Smits, D.H. Dekkers, M.A. Muller, R. Dijkman, and B.L. Haagmans Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 495 7440 2013 251 254 10.1038/nature12005
54. K. Ratia, S. Pegan, J. Takayama, K. Sleeman, M. Coughlin, S. Baliji, and A.D. Mesecar A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication Proceedings of the National Academy of Sciences of the United States of America 105 42 2008 16119 16124 10.1073/pnas.0805240105
55. C.B. Reusken, B.L. Haagmans, M.A. Muller, C. Gutierrez, G.J. Godeke, B. Meyer, and M.P. Koopmans Middle east respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study The Lancet Infectious Diseases 2013 10.1016/S1473-3099(13)70164-6
56. T. Scobey, B.L. Yount, A.C. Sims, E.F. Donaldson, S.S. Agnihothram, V.D. Menachery, and R.S. Baric Reverse genetics with a full-length infectious cDNA of the middle east respiratory syndrome coronavirus Proceedings of the National Academy of Sciences of the United States of America 110 40 2013 16157 16162 10.1073/pnas.1311542110
57. P.P. Shah, T. Wang, R.L. Kaletsky, M.C. Myers, J.E. Purvis, H. Jing, and S.L. Diamond A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and Ebola pseudotype virus infection into human embryonic kidney 293T cells Molecular Pharmacology 78 2 2010 319 324 10.1124/mol.110.064261
58. K. Shirato, M. Kawase, and S. Matsuyama Middle East respiratory syndrome coronavirus (MERS-CoV) infection mediated by the transmembrane serine protease TMPRSS2 Journal of Virology 2013 10.1128/JVI.01890-13
59. A. Shulla, T. Heald-Sargent, G. Subramanya, J. Zhao, S. Perlman, and T. Gallagher A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry Journal of Virology 85 2 2011 873 882 10.1128/JVI.02062-10
60. G. Simmons, D.N. Gosalia, A.J. Rennekamp, J.D. Reeves, S.L. Diamond, and P. Bates Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Proceedings of the National Academy of Sciences of the United States of America 102 33 2005 11876 11881 10.1073/pnas.0505577102 (Pubitemid 41170818)
61. G. Simmons, P. Zmora, S. Gierer, A. Heurich, and S. Pohlmann Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research Antiviral Research 2013 10.1016/j.antiviral.2013.09. 028
62. A.W. Struck, M. Axmann, S. Pfefferle, C. Drosten, and B. Meyer A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2 Antiviral Research 94 3 2012 288 296 10.1016/j.antiviral.2011.12.012
63. L. Sun, Y. Xing, X. Chen, Y. Zheng, Y. Yang, D.B. Nichols, and Z. Chen Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling PloS One 7 2 2012 e30802 10.1371/journal.pone.0030802
64. J.A. Tanner, B.J. Zheng, J. Zhou, R.M. Watt, J.Q. Jiang, K.L. Wong, and J.D. Huang The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus Chemistry & Biology 12 3 2005 303 311 10.1016/j.chembiol.2005.01.006 (Pubitemid 40406277)
65. A.J. te Velthuis, S.H. van den Worm, A.C. Sims, R.S. Baric, E.J. Snijder, and M.J. van Hemert Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture PLoS Pathogens 6 11 2010 e1001176 10.1371/journal.ppat.1001176
66. M. Ujike, H. Nishikawa, A. Otaka, N. Yamamoto, N. Yamamoto, M. Matsuoka, and F. Taguchi Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway Journal of Virology 82 1 2008 588 592 10.1128/JVI.01697-07 (Pubitemid 350309175)
67. M.J. van Hemert, S.H. van den Worm, K. Knoops, A.M. Mommaas, A.E. Gorbalenya, and E.J. Snijder SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro PLoS Pathogens 4 5 2008 e1000054 10.1371/journal.ppat.1000054 (Pubitemid 351811534)
68. N. Wang, X. Shi, L. Jiang, S. Zhang, D. Wang, P. Tong, and X. Wang Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 Cell Research 23 8 2013 986 993 10.1038/cr.2013.92
69. World Health Organization (WHO), (2013). Middle East respiratory syndrome coronavirus (MERS-CoV) - update (Nov 4, 2013). Global Alert and Response (GAR). Retrieved November, 4, 2013, from 〈http://www.who.int/csr/don/2013-11-04/ en/index.html〉.
70. C.Y. Wu, J.T. Jan, S.H. Ma, C.J. Kuo, H.F. Juan, Y.S. Cheng, and C.H. Wong Small molecules targeting severe acute respiratory syndrome human coronavirus Proceedings of the National Academy of Sciences of the United States of America 101 27 2004 10012 10017 10.1073/pnas.0403596101 (Pubitemid 38898719)
71. H. Yang, M. Yang, Y. Ding, Y. Liu, Z. Lou, Z. Zhou, and Z. Rao The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Proceedings of the National Academy of Sciences of the United States of America 100 23 2003 13190 13195 10.1073/pnas.1835675100 (Pubitemid 37444717)
72. L. Yi, Z. Li, K. Yuan, X. Qu, J. Chen, G. Wang, and X. Xu Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells Journal of Virology 78 20 2004 11334 11339 10.1128/JVI.78.20.11334-11339. 2004 (Pubitemid 39299674)
73. M.S. Yu, J. Lee, J.M. Lee, Y. Kim, Y.W. Chin, J.G. Jee, and Y.J. Jeong Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13 Bioorganic & Medicinal Chemistry Letters 22 12 2012 4049 4054 10.1016/j.bmcl.2012.04.081
74. K. Yuan, L. Yi, J. Chen, X. Qu, T. Qing, X. Rao, and H. Deng Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein Biochemical and Biophysical Research Communications 319 3 2004 746 752 10.1016/j.bbrc.2004.05.046 (Pubitemid 38739384)
75. G. Zhao, L. Du, C. Ma, Y. Li, L. Li, V. Poon, and Y. Zhou A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV Virology Journal 10 1 2013 266
76. B.J. Zheng, Y. Guan, M.L. Hez, H. Sun, L. Du, Y. Zheng, and J.D. Huang Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus Antiviral Therapy 10 3 2005 393 403 (Pubitemid 41151017)
77. J. Zhu, G. Xiao, Y. Xu, F. Yuan, C. Zheng, Y. Liu, and G.F. Gao Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors Biochemical and Biophysical Research Communications 319 1 2004 283 288 10.1016/j.bbrc.2004.04.141 (Pubitemid 38670191)